Skip to content

Clinical trials

Recruiting Ovarian Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Status: Recruiting Country / region: Italy Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20181
20203
20217
20226
202311
202417
202513
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting64

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione Policlinico Universitario Agostino Gemelli IRCCS15
Daiichi Sankyo4
AstraZeneca3
Eli Lilly and Company3
ARCAGY/ GINECO GROUP2
Azienda USL Reggio Emilia - IRCCS2
Centro di Riferimento Oncologico - Aviano2
IRCCS Azienda Ospedaliero-Universitaria di Bologna2
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc2
Merck Sharp & Dohme LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms64
Endometrial Neoplasms16
Breast Neoplasms12
Uterine Cervical Neoplasms11
Fallopian Tube Neoplasms9
Carcinoma, Non-Small-Cell Lung7
Colorectal Neoplasms7
Melanoma6
Pancreatic Neoplasms6
Lung Neoplasms5

Trials

Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.